Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7
Biochemical Journal · 2024
DOI: 10.1042/bcj20230404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, 2024. Verfasst von Kylie A Vestal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267, U.S.A. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Carrier Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Activins are one of the three distinct subclasses within the greater Transforming growth factor β (TGFβ) superfamily. First discovered for their critical roles in reproductive biology, activins have since been shown to alter cellular differentiation and proliferation. At present, members of the activin subclass include activin A (ActA), ActB, ActC, ActE, and the more distant members myostatin and GDF11. While the biological roles and signaling mechanisms of most activins class members have been well-studied, the signaling potential of ActE has remained largely unknown. Here, we characterized the signaling capacity of homodimeric ActE. Molecular modeling of the ligand:receptor complexes showed that ActC and ActE shared high similarity in both the type I and type II receptor binding epitopes. ActE signaled specifically through ALK7, utilized the canonical activin type II receptors, ActRIIA and ActRIIB, and was resistant to the extracellular antagonists follistatin and WFIKKN. In mature murine adipocytes, ActE invoked a SMAD2/3 response via ALK7, like ActC. Collectively, our results establish ActE as a specific signaling ligand which activates the type I receptor, ALK7.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267, U.S.A.
- Department of Pharmacology and Therapeutics, Centre for Research in Reproduction and Development, McGill University, Montreal, Quebec, Canada.
- Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH 45267, U.S.A.
- Alnylam Pharmaceuticals, Cambridge, MA, U.S.A.
ORCID-Profile: Thomas B Thompson
Förderung
- NIEHS NIH HHS
- NIGMS NIH HHS
- Foundation for the National Institutes of Health
Zitieren
APA
Vestal, K. A., Kattamuri, C., Koyiloth, M., Ongaro, L., Howard, J. A., Deaton, A. M., Ticau, S., Dubey, A., Bernard, D. J., & Thompson, T. B. (2024). Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7. Biochemical Journal. https://doi.org/10.1042/bcj20230404
Vancouver
Vestal KA, Kattamuri C, Koyiloth M, Ongaro L, Howard JA, Deaton AM, et al. Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7. Biochemical Journal. 2024. doi:10.1042/bcj20230404
BibTeX
@article{Vestal2024,
author = {Vestal, Kylie A and Kattamuri, Chandramohan and Koyiloth, Muhasin and Ongaro, Luisina and Howard, James A and Deaton, Aimee M and Ticau, Simina and Dubey, Aditi and Bernard, Daniel J and Thompson, Thomas B},
title = {Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7},
journal = {Biochemical Journal},
year = {2024},
doi = {10.1042/bcj20230404}
}
EUVIMED